James R Howe
Overview
Explore the profile of James R Howe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
3908
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Tow D, Tran C, Borbon L, Ridder M, Li G, Kaemmer C, et al.
bioRxiv
. 2023 Apr;
PMID: 37066322
Small bowel neuroendocrine tumors (SBNETs) originate from enterochromaffin cells in the intestine which synthesize and secrete serotonin. SBNETs express high levels of tryptophan hydroxylase 1 (Tph1), a key enzyme in...
22.
Suraju M, Snow A, Nayyar A, Chang J, Sherman S, Hoshi H, et al.
J Surg Res
. 2022 Nov;
283:479-484.
PMID: 36436283
Introduction: Peritoneal metastases (PMs) following resection of pancreatic intraductal papillary mucinous neoplasms (IPMNs) are rare. Consequently, prevalence, risk factors, and prognosis are not well known. We reviewed our institution's experience...
23.
Sedlack A, Saleh-Anaraki K, Kumar S, Ear P, Lines K, Roper N, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428741
Neuroendocrine neoplasia (NENs) are a complex and heterogeneous group of cancers that can arise from neuroendocrine tissues throughout the body and differentiate them from other tumors. Their low incidence and...
24.
Ziogas I, Tasoudis P, Borbon L, Sherman S, Breheny P, Chandrasekharan C, et al.
Ann Surg Oncol
. 2022 Oct;
30(1):148-160.
PMID: 36227392
Background: Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are rare, aggressive tumors with poor prognosis. The World Health Organization 2017 and 2019 classifications further subdivided G3 NENs into G3...
25.
Ziogas I, Dillon J, Chandrasekharan C, Howe J
Ann Surg Oncol
. 2022 Oct;
30(1):161-162.
PMID: 36209329
No abstract available.
26.
Vargas S, AghaAmiri S, Ghosh S, Luciano M, Borbon L, Ear P, et al.
Mol Pharm
. 2022 Sep;
19(11):4241-4253.
PMID: 36174110
Dye design can influence the ability of fluorescently labeled imaging agents to generate tumor contrast and has become an area of significant interest in the field of fluorescence-guided surgery (FGS)....
27.
28.
Borbon L, Tran C, Sherman S, Ear P, Chandrasekharan C, Bellizzi A, et al.
Ann Surg Oncol
. 2022 Jul;
29(11):6936-6946.
PMID: 35802214
Background: Grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are aggressive tumors with poor survival outcomes for which medical management is generally recommended. This study sought to evaluate outcomes of...
29.
MacFarland S, Xie H, Dent M, Greed B, Plon S, Scollon S, et al.
J Pediatr Gastroenterol Nutr
. 2022 May;
75(1):56-58.
PMID: 35622075
Juvenile polyposis syndrome (JPS) is a childhood polyposis syndrome with up to a 50% lifetime risk of gastrointestinal cancer. Germline pathogenic variants in BMPR1A and SMAD4 are responsible for around...
30.
Tran C, Borbon L, Mudd J, Abusada E, AghaAmiri S, Ghosh S, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454817
Gastroenteropancreatic neuroendocrine neoplasms (GEP NENs) are rare cancers consisting of neuroendocrine carcinomas (NECs) and neuroendocrine tumors (NETs), which have been increasing in incidence in recent years. Few cell lines and...